本月全球药品研发进展取得成效的药物共有57个,与上月数量一样。进入注册阶段的有27个,较上月减少5个。其中,3个为全球首次注册的药品,在新市场补充注册的为24个。进入注册前阶段的有9个,较上月减少7个。进入Ⅲ期临床研究阶段的有21个,较上月增加12个。 There were 57 drugs that made progress in global drug development this month, the same as last month. There were 27 registrations, a decrease of 5 from the previous month. Among them, 3 are the first drugs registered in the world and 24 are newly registered in the new market. There were nine prior registrations, a decrease of seven from the previous month. Into the phase Ⅲ clinical research phase of 21, an increase of 12 from the previous month.